Back to search

Switzerland· 62752001

Aplona, Pulver zur Herstellung einer Suspension zum Einnehmen

A pectin product containing mali fructus siccati pulvis (malus sylvestris (l.) mill., fructus), registered in Switzerland by athenstaedt AG and dispensed under Swissmedic category D. The same ATC class is registered in 3 of our 19 countries.

Cat D (Swissmedic)ATC A07BC01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedAplona, Pulver zur Herstellung einer …ATCA07BC01REGISTER NO.62752001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Pectin is registered in 3 of 19 countries.

Countries holding a registration under ATC A07BC01 (pectin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose

Pectin · ATC A07BC01

3 / 19 countries

  • Finlandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
mali fructus siccati pulvis (Malus sylvestris (L.) Mill., fructus)
Manufacturer
athenstaedt AG
Country
Switzerland (CH)
ATC code
A07BC01
ATC class
Pectin
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for pectin.

Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pectin · interactions on record

8 records

  • 8 moderate

Most severe, free to view

  • DigitoxinC01AA04moderate
  • DigoxinC01AA05moderate
  • SimvastatinC10AA01moderate
  • LovastatinC10AA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/11c8e18c-a5bc-457c-b5c3-b3cb61b5693d
GET /v1/drugs/11c8e18c-a5bc-457c-b5c3-b3cb61b5693d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Phytoarzneimittel"
}

See everything about pectin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.